Quantitative analysis of resistance to natural killer attacks reveals stepwise killing kinetics

Paul J Choi1, Timothy J Mitchison

  • 1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. paulchoi@post.harvard.edu.

Insights

Cancer cells evade immune attacks through varied survival kinetics. A specific protein, PI-9, confers resistance by requiring multiple immune cell attacks for cancer cell death.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Kinetics

Background:

  • Cancer cells possess molecular mechanisms for immune evasion, often appearing as reduced cell death at the tissue level.
  • Individual cell survival and death kinetics during immune attack show significant variation.
  • Natural killer (NK) cell cytotoxicity is a key component of the immune response against cancer.

Purpose of the Study:

  • To investigate the kinetics of immune evasion in cancer cells.
  • To characterize the survival time distributions of cancer cells under immune attack.
  • To determine if resistance to immune killing is a measurable quantity with a distinct kinetic signature.

Main Methods:

  • Tracking individual cancer cell survival and death times using multiplexed reporters.
  • Analyzing survival time distributions (exponential vs. nonexponential) in response to natural killer cell attacks.
  • Developing and validating a quantitative model based on independently measured parameters.

Main Results:

  • Observed broad variation in immune evasion kinetics among different cancer cell lines.
  • Identified exponential survival time distributions in some cancer lines, with slower killing correlating to reduced rate constants.
  • Demonstrated a nonexponential survival time distribution in serpin protein PI-9-expressing cancer cells, indicating increased resistance.
  • Provided evidence that PI-9-expressing cells require multiple immune attacks for elimination.

Conclusions:

  • Cancer cell resistance to immune attack is not uniform and exhibits distinct kinetic signatures.
  • The serpin protein PI-9 significantly enhances cancer cell resistance to immune-mediated killing.
  • Resistance to immune attack is a finite and quantifiable property of cancer cells.